Kilitch Drugs (India) Limited (BOM:524500)
137.60
-14.90 (-9.77%)
At close: Mar 27, 2026
Kilitch Drugs (India) Market Cap
Kilitch Drugs (India) has a market cap or net worth of 5.33 billion as of March 27, 2026. Its market cap has increased by 6.17% in one year.
Market Cap
5.33B
Enterprise Value
5.28B
Revenue
2.07B
Ranking
n/a
PE Ratio
19.13
Stock Price
137.60
Market Cap Chart
Since March 5, 2002, Kilitch Drugs (India)'s market cap has increased from 14.33M to 5.33B, an increase of 37,099.86%. That is a compound annual growth rate of 27.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 5.33B | -5.51% |
| Dec 31, 2025 | 5.64B | 7.84% |
| Dec 31, 2024 | 5.23B | -12.48% |
| Dec 29, 2023 | 5.98B | 145.95% |
| Dec 30, 2022 | 2.43B | -37.79% |
| Dec 31, 2021 | 3.91B | 162.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wanbury | 8.44B |
| Fredun Pharmaceuticals | 8.28B |
| Anuh Pharma | 7.16B |
| Bharat Parenterals | 6.84B |
| Kopran | 5.88B |
| Sudarshan Pharma Industries | 5.74B |
| Jenburkt Pharmaceuticals | 4.45B |
| Albert David | 3.71B |